BI 655066/ABBV-066/Risankizumab Compared to Placebo in Patients With Active Psoriatic Arthritis

Clinical trial NCT02719171 · COMPLETED

Trial details

NCT number: NCT02719171
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Arthritis, Psoriatic

Start date: 2016-04-01
Primary completion: 2017-05-01
Enrollment: 185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.